20.12.11 3th call winner projects
AriSLA Call for Research Proposals 2011 Winner Projects
Few days after the end of the review process of the third Call for projects, AriSLA is glad to announce the winner projects that will be supported by AriSLA contribution of about 1.197.125 euros.
Funded projects have been chosen through a peer-review evaluation process that involved 40 international experts. The peer review methodology guarantees the impartiality and transparency of the procedure, and thank to the work of the International Scientific Committee, 7 winner projects of excellence have been identified .
To the third 2011 Call 55 projects proposals have been submitted, 16 Full Grants and 39 Pilot Grants, for a total request of contribution of about 7 ml euros.
Approved financial contribution for each project varies from 50.000 to 300.000 euros that will be granted over a period of time between 12 and 36 months.
Following the winner projects of the 2011 Call:
Full Grant:
ALS_ HSPB8: Upregulation of HSPB8 as potential therapeutic approach in familial and sporadic ALS
Principal Investigator: Angelo Poletti, Università degli Studi di Milano
Partner 1: Serena Carra, Università degli Studi di Modena e Reggio Emilia
HDACALS – 2: Isoform-selective deacetylase inhibitors in experimental models of ALS: molecular and therapeutic effects
Principal Investigator: Alberto Chiarugi, Università degli Studi di Firenze
IMMUNALS: Pathogenetic role and potential clinical exploitation of the CCL2/CCR2 axis in the regulation of immune responses in ALS
Principal Investigator: Caterina Bendotti, Istituto di Ricerche Farmacologiche “Mario Negri”, Milano
Partner 1: Massimo Locati, Fondazione Humanitas per la Ricerca, Milano
SARDINIALS: Genomic studies of ALS in Sardinia
Principal Investigator: Adriano Chiò, Università degli Studi di Torino
Partner 1: Bryan Traynor, National Institute of Health, Bethesda, USA
Partner 2: Giuseppe Borghero, Università degli Studi di Cagliari
Partner 3: Maura Pugliatti, Università degli Studi di Sassari
Pilot Grant:
ALS-MAI: ALS: the role of microglia, astrocytes and inflammation *
Principal Investigator: Luca Muzio, Fondazione Centro San Raffaele del Monte Tabor, Milano
eCypALS: Extracellular cyclophilin A as a possible therapeutic target for amyotrophic lateral sclerosis
Principal Investigator: Valentina Bonetto, Istituto di Ricerche Farmacologiche “Mario Negri”, Milano
SaNeT-ALS: Sigma-1 receptor as a new potential therapeutic target for ALS
Principal Investigator: Daniela Curti, Università degli Studi di Pavia
